30-inch NEC PACS Display wins FDA Approval
NEC Display Solutions of America announced this week the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis.
NEC Display Solutions of America announced this week the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis.
The four-megapixel MD301C4 was created for medical imaging and picture archiving and communication system (PACS) in hospitals, doctor offices, urgent care centers and other health care facilities. This medical-grade display includes patented technologies that make healthcare employees’ work more productive and accurate, the company says, offering factory-adjusted DICOM calibration with self-monitoring brightness. With an optional MDSVSENSOR2 color calibration sensor, the MD301C4 also supports standalone calibration and exact monitor matching, while enhancing calibration and white-point matching for outstanding DICOM GSDF conformance.
The MD301C4 is available at an estimated street price of $3,499. The display ships with a 5 years parts and labor warranty with Advanced Overnight Exchange.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
